-
Diagnostics World | Kailos Genetics and the Huntsman Cancer Institute (HCI) at the University of Utah have won a $2.4 million grant from the National Institutes of Health to develop a clinical-grade test for circulating tumor DNA (ctDNA) to monitor patients for breast cancer disease recurrence.
Jun 22, 2016
-
MIT Technology Review |
The Tech Review editors pick the 50 companies that best combine innovative technology with an effective business model. Several diagnostics and biotech companies make the list, including T2 Biosystems (#34), Oxford Nanopore (#22), and Veritas (#40).
Jun 21, 2016
-
Diagnostics World News | On Friday, the U.S. Food and Drug Administration (FDA) granted emergency use authorization for Hologic’s new, diagnostic assay for Zika virus infection.
Jun 20, 2016
-
Forbes |
Elizabeth Holmes speaking at the Forbes Healthcare Summit last December. Credit: Glen Davis If there is working technology at Theranos, the embattled startup that promised to revolutionize blood tests by replacing needles in veins with finger pricks at a lower price with faster speed, you wouldn't be able to tell. To [...]
Jun 17, 2016
-
THCB |
CDC says that 86% of healthcare dollars are spent on patients with chronic illness, and the largest, fastest, and most preventable diagnosis is the most acute of all: septicemia. 13% of the time, patients die.
Jun 17, 2016
-
STAT |
The gene-editing technique CRISPR has been used for the first time to create a diagnostic that can differentiate between two strains of the Zika virus.
Jun 15, 2016
-
Forbes |
Yesterday, Walgreens, the U.S. drug-store arm of global pharmacy giant Walgreens Boots Alliance, finally terminated its deal with Theranos, the blood-testing startup that once aimed to disrupt the laboratory business but now is fighting for its survival.
Jun 13, 2016
-
Diagnostics World Invitae Corporation launched CancerCHECK (Cancer Complete Hereditary Evaluation Clinic Kit), this week, a comprehensive toolkit that provides checklists, information, and customized support for clinicians considering genetic testing for hereditary breast, ovarian, and colorectal cancers.
Jun 8, 2016
-
Washington Post |
British scientists took a major step toward bringing personalized medicine to mental health on Tuesday, announcing that they had developed a blood test that can accurately predict whether or not you'll respond to the conventional, commonly prescribed antidepressants on the market.
Jun 8, 2016
-
Scientific American Blog Network |
Illustration breaks down the microscopic mechanisms behind a global threat
Jun 3, 2016
-
Diagnostics World Brief | Definiens and MolecularMD announced a partnership today to combine MolecularMD’s expertise in specialty diagnostic assays with Definiens’ quantitative tissue read-outs. Together the two companies hope to offer patient stratification using quantitative tissue assays for clinical development and diagnostics.
Jun 2, 2016
-
Diagnostics World News | Trillions of bacteria dwell in, on, and among us in the oceans, air, soil, plants, and animals, and on May 13, the White House Office of Science and Technology Policy announced its plan to drive research exploring the microbiome. The National Microbiome Initiative (NMI) will invest $121 million to support research on the microbiome, develop technologies to study and share results, and expand the microbiome workforce.
Jun 1, 2016
-
ReadWrite |
Wearables are a great start to monitoring your level of fitness, but they have further to go to give you and your doctor a detailed view of your health.
May 27, 2016
-
Diagnostics World | Qiagen received a warning letter from the US Food and Drug Administration (FDA) last week detailing repeated complaints for high false positive rates for Qiagen’s QuantiFERON-TB Gold (QFT) test device—its blood test used for diagnosing tuberculosis.
May 25, 2016
-
STAT |
Whole exome sequencing identifies a mutation that claimed the lives of two newborns.
May 24, 2016
-
Diagnostics World News | Diagnostics World News will be attending the Next Generation Diagnostics Summit in Washington, D.C. this August, and we are looking forward to four days filled with diagnostics challenges, solutions, and advances. The Summit includes 13 different conference programs, and here is just some of what we have highlighted.
May 20, 2016
-
Forbes |
Until now, Theranos and those close to the company could claim that its problems were limited to its laboratory in Newark, California, and that it had really done a fine job in Arizona, where most of its testing centers are. That claim lies demolished.
May 19, 2016
-
Diagnostics World Brief | Foundation Medicine, Inc. today announced that the U.S. Patent and Trademark Office has issued U.S. patent number 9,340,830, entitled, “Optimization of Multigene Analysis of Tumor Samples.” The patent, which is assigned to Foundation Medicine, includes fundamental claims describing methods of analyzing a cancer patient’s tissue or blood specimen to detect multiple classes of genomic alterations.
May 17, 2016